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ABSTRACT 
For various reasons, the health status of a man declines with time depending on his environment, food and beverage intake, 
mentality, stress level, age etc. Fortunately, the ability of man to combat various diseases has advanced due to Biotechnology 
that is emerging worldwide and Nigeria is not left out. Footings in pharmaceutical biotechnology are embedded in the ability of 
plants, microorganism and animals to produce low and high molecular weight compounds which are functional for mankind and 
animals as therapeutics. The development in medical biotechnology has brought different ideas and mechanisms to combat the 
challenges of deteriorating health by making use of biological parts to treat patients. As with any new innovation, biotechnology 
comes with a lot of potentials but also with lots of risks, ethical and legal dilemma, hence, the need for law and regulations to 
serve as guide in the emerging industry. This article examined these criminal and civil issues using doctrinal research 
methodology and the analytical approach to explore the works of several authors in the field of biotechnology to examine its 
development. The study thereafter made recommendations on how to create an effective system that will harness the potentials 
of the biotechnology especially in the field of pharmacy and medicine. The study concluded that biotechnology can only excel 
for the benefits of mankind and the environment when pharmaceutical companies, researchers, scholars and government abide 
by the ethical and legal provisions on biotechnology in order to avoid the consequences of the risks. 
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INTRODUCTION 
 
The concept of Biotechnology goes as far back as the 
beginning of humanity, and it began with the art of agricultural 
revolution practiced by the ancient men, involving the use of 
artificial picking for livestock, crops and other domesticated 
animals. The modern day art of biotechnology started with the 
discovery of vaccines by Edward Jenner, and the invention of 
antibiotics by Alexander Fleming. As an advantage to man, 
microbial products and plants have been used for centuries, as 
natural preservatives in the protection of vegetables, milk and 
fruits, in the form of beer, bread, cheese, wine, yoghurt, 
pickles, vinegar, and many more fermented materials 
(Ramana et all.,2017). 
 According to authors, Biotechnology is technology that 
has been based on biology. It harnesses the cellular and other 
bio-molecular procedures to build technological equipment, 
procedures and products that can help to improve the quality 
of lives and enhance human health. (Bio.org., 2018). Recently, 
the perception of this technology is redefined away from one 
that instills the sense of danger and hesitation to that which is 
filled with prospect and hope. People are overcoming some of 
the biological limitations imposed by nature. This is further 
demonstrated through new trends such as Assisted 
Reproduction Technology, organ transplantation as well as 
genetic mutation and re-engineering. (Plein, 2018)  
 The rise in biotechnology will inevitably give rise to new 
moral, cultural, religious and of course, most importantly, 
legal questions because its exploits in knowledge and 
capabilities has given rise to new challenges (Clark and 
Pazdernik, 2015) one of such challenges that has arisen is the 
issue of proprietary rights and interests that can be held over 
body parts. This forms the crux of this research. The fact that 
the main resource used as “tool of trade”  in biotechnology are 
things like body cells, organs and tissues brings to the fore 
questions  such as ownership and proprietary interests in 
materials being used. This seems to be testing the notion that 
the conservative and traditional belief that these body parts are 
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not supposed to be claimed by any individual (Dunham, 
2008).  
 Although there has always been the fear of the 
consequences of biotechnology, it keeps advancing with 
regards to the advantageous applications and daring risks 
(Future of Life Institute, 2018). This is evident in the 
“increasing pace of progress – from low cost DNA sequencing 
to rapid gene synthesis to precision genome editing.” Another 
area of concern is the fact that DIY scientists take biotech 
instruments out of the lab.  
 Modern biotechnology has evolved from a molecular basis 
that grew from ‘increasing biochemical understanding of 
genetics and physiology’, (Clark and Pazdernik, 2015). This 
development will aid researchers, scholars, pharmaceutical 
companies, forensic scientists to advance biotechnology faster 
to the advantages of man’s health and environment. The 
Criminal Justice system across the globe will also benefit from 
modern biotechnology with the its impact on forensic 
laboratory in determining who commits a crime through the 
use of the deoxyribonucleic acid (DNA) of both the victim and 
the accused person. A bright point is that many of the 
advantages of biotechnology are visible and real, while many 
of the fears are based on doubts and assumptions. It is however 
more favourable to be proactive and aware of the risks rather 
than wait for the actualization of the risks before attempting to 
seek solutions, (Future of Life Institute, 2018). This study 
therefore examined the importance of biotechnology to 




There have been numerous definitions given to the concept of 
biotechnology. Albert Sasson reported that the first known 
definition of biotechnology was propounded by Karoly Ereky, 
a Hungarian agricultural engineer, who defined it in a piece 
titled “Biotechnology of Meat, Fat and Milk Production in 
Large Scale Agricultural Enterprises”,(Albert, 2005). 
According to him, biotechnology is the methods and 
techniques which allow the substances to be produced from 
raw materials using living organisms. Since 1919, Karoly 
Ereky is regarded as the father of biotechnology across the 
globe (Fari and Kralovansky, 2006).  
 Biotechnology has also been described as technology that 
is based on biology which “harnesses cellular and bio 
molecular processes to develop technologies and products that 
help improve our lives and the health of our planet”, 
(Biotechnology Innovation Organization, 2019). According to 
Norwegian University of Technology, “Biotechnology is 
technology that utilizes biological systems, living organisms 
or parts of this to develop or create different products”. 
 Biotechnology has been defined as the end result of years of 
man’s experience with the use of living tissues and 
fermentation to make products useful for mankind 
(docslide.us 2018). 
 Further, the Oxford Online Dictionary of English defines 
biotechnology as “the exploitation of biological processes for 
industrial and other purposes especially genetic manipulation 
of microorganisms for the production of antibiotics, hormones 
etc”.  (oxforddictionaries.com 2018) 
In law, biotechnology has been defined by Article 2 of the 
Convention on Biological Diversity (1992) to mean “any 
technological application that uses biological systems, living 
organisms, or derivatives thereof, to make or modify products 
or processes for specific use” 
 This   work   will,   however,   focus   more   on   medical 
biotechnology, also     known     as     red     biotechnology 
(biotechnologie.de 2018). This is because the challenge in the 
concept of ownership of these biological materials has to do 
with human parts used as materials in medical biotechnology. 
More so, the improper transfer or illegal sale is totally criminal 
and it is punishable under the penal laws of any jurisdiction 
across the globe. In simple terms biotechnology is a biology 
based technology (Biotechnology Industry Organization 
2014).  It  entails  the manufacture  of  products  aimed  at  
improving  the  quality  of human  existence  from  biological  
processes,  organisms  or systems (Whatls.com 2014).   The 
use of biotechnology has assisted in harnessing and improving 
life over the years. Before the advancement in the technology, 
there has been the use of microorganisms for the manufacture 
of useful food like bread, cheese and also for the preservation 
of other daily needs (Biotechnology Industry Organization 
2014). 
 From all these definitions, it is apparent that biotechnology 
is developing across the globe for the satisfaction of the human 
race in order to prolong lives and increase food production 
 
TYPES OF BIOTECHNOLOGY 
According to European Intellectual Property Right (IPR 
2014), there are about three sectors in which Biotechnology 
can be subdivided into and these may intersect, namely:  
Healthcare biotechnology or red biotechnology which is very 
pertinent in the discovery of drugs like insulin, erythropoietin, 
etc. and contemporarily has today revamped “outcomes for 
patients and addressing unmet medical needs for the future”.  
The second sector is Agriculture biotechnology or green 
biotechnology. This plays important roles in plants 
enhancement so as to boost their immunity to “disease, 
tolerance for herbicides or difficult environment conditions, or 
to achieve higher yields with less inputs (water, fertilizers, 
etc.)” (IPR  2014). 
 Industrial biotechnology or white technology is the third 
sector. This represents new innovation in both the agricultural 
and health areas; this sector encompasses the application of 
biotechnology-based tools to traditional industrial processes 
(“bioprocessing”) and the manufacturing of bio-based 
products (biofuels, bio-plastics and bio-based chemicals) 
(Ibid). 
 
BENEFITS OF BIOTECHNOLOGY TO HUMANS 
Without any gain saying, biotechnology has developed to the 
advantage and interest of mankind in various ways which 
include; 
 According to AMGEN Incorporation (2019), the 
following are the emerging medical treatment that 
biotechnology has advanced for the benefits of mankind; 
a) *Gene therapy: involves inserting genes into the cells of 
patients to replace defective genes with new, functional 
genes. The field is still in its experimental stages but has 
grown greatly since the first clinical trial in 1990. 
Legal framework for advancement in biotechnology 
 Afr. J. Biomed. Res. Vol. 22, No.3 (September) 2019 Imosemi.       223 
 *Stem cells: are unspecialized cells that can mature into 
different types of functional cells. Stem cells can be grown 
in a lab and guided toward the desired cell type and then 
surgically implanted into patients. The goal is to replace 
diseased tissue with new, healthy tissue. 
 *Nanomedicine: aims to manipulate molecules and 
structures on an atomic scale. One example is the 
experimental use of nanoshells, or metallic lenses, which 
convert infrared light into heat energy to destroy cancer 
cells. 
 *New drug delivery systems: include microscopic 
particles called microspheres with holes just large enough 
to dispense drugs to their targets. Microsphere therapies 
are available and being investigated for the treatment of 
various cancers and diseases. 
 
b) Cultivation Good quality Crops:  Agricultural 
biotechnology assists in improvement of plant quality 
because of the production of transgenic varieties of plants, 
as well as plants that can resist draught and various 
diseases (Chikaire et al 2012). 
 
c) Livestock Improvement:  New vaccines for diseases 
affecting livestock are produced through biotechnology.  
There is also the development of DNA vaccines rinderpest, 
foot and mouth diseases and cowdriosis among other 
livestock diseases. (Chikaire et al 2012). 
 
d) Facilitating the usage of renewable energy: 
Biotechnological methods and products enable scientists 
to use renewable energy resources and also helps them to 
develop reusable or commercially viable by-products of 
biotechnology, this will increase the level of productivity 
and increase the potentials that can be derived from energy 
and material resources by ensuring ‘maximum recycling’ 
with minimal effluents (Chikaire et al 2012).  
 
e) Modification in Genetic Make-up: The use of 
biotechnology enhances the genetic make-up of plants and 
animals by inserting new genes that will benefit the 
organism or removing unwanted genes. It also changes the 
way plants are grown and animals are raised while 
boosting their values to the farmers and customers alike. 
(US National Science and Technology Council 2010). In 
short, modern trends in biotechnology have been providing 
so many opportunities for the development of improved 
qualities of product, plants and farmed animals, while 
retaining its economic benefits.  
 
WHAT ARE THE RISKS OF BIOTECHNOLOGY? 
Biotechnology may be more harmful than other scientific 
fields since microbes are very tiny and could be stubborn to 
detect. Furthermore, “Engineered cells could divide on their 
own” and spread wildly with unwanted implications, (Future 
of Life institute, 2018).  
a) Unpredictable Consequences: In 2014, scientists in the 
Center for Disease Control became exposed to the flu, 
Ebola and anthrax after repeated failed attempts at finding 
cures. Also, in 2011, a Netherlands Professor came under 
scrutiny when he made attempts to publish the details of a 
deadly airborne version of the flu virus engineered by his 
lab. In the process of studying toxins and viruses for the 
purpose of understanding the dangers posed by them as 
well as their cures, a deadly substance could be mishandled 
and released by error, and it could lead to great danger to 
the public health (Future of Life institute, 2018). Another 
example is Mosquitoes which are disease carriers and 
carry deadly and harmful pathogens like dengue, Zika and 
malaria. Recently, concerns have been raised by 
Lawmakers, civilians and scientists regarding a mosquito 
prevention strategy which would function to genetically 
change and destroy the specie of mosquitoes that carry 
diseases. The technology which is known as a gene drive 
is fashioned to spread a gene amongst a population hastily, 
by means of sexual reproduction. With such technology, it 
is slightly possible that the gene drive once released to 
outer space, could mutate thereby circulating genes not 
predicted by the scientists (Francis, 2003).  
  In the course of finding cure to HIV, scientists dug 
into the DNA of people who are supposedly immune to the 
virus, and discovered that those people who are immune 
had a mutated protein on the blood+ cells surface which 
acts as a landing ground for HIV. Hence, scientists 
concluded that removing its genes from the cells of those 
at-risk or already affected could turn out to be a long 
lasting cure for HIV and AIDS. The process which 
involves performing a non-complex gene surgery with  a 
“DNA scissors called CRISPR/Cas9”  would help cure 
cancer, HIV and other genetic diseases. The trials of the 
“CRISPR/Cas9 in the cell of human have created 
problematic results due to mutations being found in areas 
of the genome that ought not to be targeted for DNA 
modification (Charleston et all 2018) 
b) Weaponizing Biology: Recently, there was an outbreak of 
diseases known as the Zika virus and Ebola. These 
viruses’s had a natural origin. However, the effect is that 
there could be future outbreaks if biotechnology is used in 
a malicious manner. The creation and release of a 
bioweapon in form of an infectious disease or a poison 
would be difficult to detect and more difficult to stop 
because deadly cells have the capacity to keep circulating 
even after they are initially deployed. Any threat with 
regards to this is taken with utmost seriousness by the US 
government (Future of life institute, 2018) 
 Bioweapons are developed by both developed and 
developing countries with the know-how and resources to 
make them. An example is the case of North Korea getting 
things ready in case of external attack, by preparing an 
arsenal comprising of “anthrax, botulism, hemorrhagic 
fever, plague, smallpox, typhoid, and yellow fever.” There 
is also the assumption that terrorists or other malicious 
groups could employ the use of bioweapons. There have 
been situations where biological or chemical weapons 
have been used, and an example is the incident that 
occurred after the 9/11 attack known as the anthrax scare. 
Toxic cells were circulated via mail and it led to the death 
of 5 people (Robert, 2017). 
 The threats of bioweapon should not be 
underestimated simply because it requires less expertise. 
The recent developments in biotechnology show that 
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bioweapons can successfully be made at little cost and 
without a specialized lab or scientific knowledge. The cost 
to chemically manufacture strands of DNA is falling 
rapidly, meaning it may one day be \affordable to ‘print’ 
deadly proteins or cells at home. Bioweapons could also 
be used to erase an unwanted ethnic race or set of people 
(Joseph et all, 2002). 
 
THE ETHICS OF BIOTECHNOLOGY 
In order to effectively change lives, biotechnology does not 
necessarily have to be dangerous. Humans have been 
modifying the genes of animals and plants for decades and 
only started to modify his own a while back. The emergence 
of cutting-edge instruments like CRISPR/Cas9 has raised a 
number of ethical concerns (Charleston, 2018). The question 
has been raised whether modifying the genes of humans 
relates to the act of “playing God”. Most gene mutations that 
relates to diseases usually comes with an early death certainty 
or the risk of conditions such as Alzheimer’s disease. Hence, 
it is difficult to decide the limits of the surgery and under what 
situations it should be carried out since the surgery could cause 
damage to the genetic build. Researchers and Lawmakers have 
battled with these concerns for years (Charleston, 2018). 
 The United Nations Universal Declaration on the Human 
Genome and Human Rights (1997) in Article 1 provides that 
“this Declaration addresses ethical issues related to medicine, 
life sciences and associated technologies as applied to human 
beings, taking into account their social, legal and 
environmental dimensions”. The law further states that 
Human dignity and rights are to be totally revered while the 
welfare of individuals must be paramount, (Article 3, United 
Nations Universal Declaration on the Human Genome and 
Human Rights, 1997). In relation to decision taking on 
bioethical issues, “Professionalism, honesty, integrity and 
transparency in decision-making should be promoted, in 
particular declarations of all conflicts of interest and 
appropriate sharing of knowledge. Every endeavour should be 
made to use the best available scientific knowledge and 
methodology in addressing and periodically reviewing 
bioethical issues” (Article 18, United Nations Universal 
Declaration on the Human Genome and Human Rights, 1997). 
 Every country must set up a multidisciplinary and pluralist 
ethics committee, promoted and supported at the appropriate 
level in order to:  
“(a) assess the relevant ethical, legal, scientific and social 
issues related to research projects involving human beings;  
(b) provide advice on ethical problems in clinical settings;  
(c) assess scientific and technological developments, 
formulate recommendations and contribute to the 
preparation of guidelines on issues within the scope of this 
Declaration;  
(d) foster debate, education and public awareness of, and 
engagement in, bioethics, (Article 19, United Nations 
Universal Declaration on the Human Genome and Human 
Rights, 1997).” 
Researchers all over the world are advised to strictly adhere to 
the ethical provisions under this International Instrument. 
 
 
GOVERNMENT’S EFFORTS ON BIOTECHNOLOGY 
Nigeria established the National Biosafety Management 
Agency (NBMA) in 2015 to regulate the country’s bio-
technology law and ensure oversight for utilizing and 
commercializing biotechnology products with a view to 
strengthening Nigeria’s food security (Attache Report GAIN. 
2017).  Furthermore, In recent times, Nigerian Government 
has shown interest in acquiring biotechnology know-how. 
There have been formulation of policies for biotechnology and 
establishment of laboratories and agencies for the promotion 
of biotechnology in Nigeria. Such programmes includes: the 
International Institute for Tropical Agriculture (IITAO), 
National Biotechnology Development Agency (NABD) 
Abuja, National Center for Genetic Resources and 
Biotechnology, NAGRAB, Ibadan, National Biosafety 
Frameworks, Federal Ministry of Environment, Abuja, and 
the Government of Nigeria’s Sheda Science and Technology 
Complex (SHESTCO), (Uche, 2013)  
In Nigeria, the International Institute for Tropical Agriculture 
(IITA) and the Government of Nigeria’s Sheda Science and 
Technology Complex (SHESTCO) are the main institutes that 
oversee the process and application of basic biotechnology 
research. At the facilities, Nigerian researchers have the 
opportunity to carry out researches related to the field of 
biotechnology. An example of the recent progress of 
researchers is the transformation of a variety of local tomatoes.   
Also, the institute is involved in carrying out basic research on 
bio-engineered cowpea. Sources have claimed that the Bill 
and Melinda Gates foundation have plans to set up in Nigeria, 
a laboratory for biotechnology research, which would help 
with developing the capacity of biotechnology in Nigeria and 
other African countries. This is important as complex 
biotechnology instruments are now used worldwide to create 
and also help crops grow better, (Uche, 2013).   
An important effort of the government towards biotechnology 
is the passing into Law of the National Biosafety Management 
Agency Act of 2015. It is an Act of the National Assembly 
which guides Biotechnology in Nigeria. The Act serves as a 
precaution, and defines criteria for the effective control and 
management of biotechnology in Nigeria.  (NBMAA, 2015) 
 
THE LEGAL FRAMEWORK ON BIOTECHNOLOGY  
The National Biosafety Management Agency Act of 2015 is 
the primary Act guiding biotechnology in Nigeria.  The Act 
establishes   the   National   Biosafety   Management   
Agency which is the national authority on Biosafety related 
matters in Nigeria and specifies the penal liabilities that 
experts may execute.  
 
CRIMINAL LAW 
 Section  2  of  the  National Biosafety Management Agency 
Act of 2015  sets  out  the  objectives  of  the agency as: 
“    (b)    safeguard    human    health,    biodiversity    and    the 
environment from any potential adverse effect of genetically 
modified organisms including food safety: (c) ensure safety in 
the   use   of   modern   biotechnology   and   provide   holistic 
approach to the regulation of genetically modified organisms 
(d)  provide  measures  for  the  case-by-case  assessment  of 
genetically  modified  organisms  and  management  of  risk  
in order  to  ensure  safety  in  the  use  of  genetically  modified 
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organisms to human health and the environment: (e) provide 
measures for effective public participation public awareness 
and access to information in the use and application of modern 
biotechnology  and  genetically  modified  organisms;  and  (f) 
ensure that the use of the genetically modified organisms does 
not  have  adverse  impact  on  socio-economic  and  cultural 
interests either at the community or national level.” Section 3 
of the Act also sets out the functions and powers of the agency. 
One of such functions is set out in paragraph F “develop risk 
management plan and strategy for protecting human health, 
biological diversity and the environment from potential    risks    
associated    with    genetically    modified organisms.” 
The Act also makes provisions for the negative impact 
genetically motivated organisms may have on humans and the 
environment at large which may result in criminal 
responsibility as shown in section 34. Under the provisions of 
sections 35 (1) and (2), the Biosafety Management Act, 
“where GMO-related activities are carried out without prior 
approval, or where an individual (or entity) supplies 
false  information relating to GMO activities, or contravenes 
any provision of the Act, liability arises for any damage that 
may occur as a result of such activity”.   
 The   Act   is   a   legal   regime   that   ensures   that   all 
biotechnology products that are imported are compulsorily 
certified and labeled. The Act provides details on the handling, 
exchange and proper use of products and new agricultural 
biotechnology, to ensure that the safety of human health and 
the environment at large is secured.  Further, the Act seeks to 
ensure that modern biotechnology is applied in a safe manner. 
The Act provides for penalties for offences related to the Act. 
In    Nigeria,    pharmaceuticals    and    biologics    cannot    be 
prescribed to Hospitals and patients until their usage has been 
legalized by National Food and Drug Agency Commission 
(NAFDAC).  The  same  is  the  situation  in  the  United  States 
where  the  Food  and  Drug  Administration  evaluates  new 
medicines  and In the  European Union,  where the  European 
Medicines   Agency   is   responsible   for   that   regulation. 
(AMGEN 2019). 
 
CIVIL LAWS ON BIOTECHNOLOGICAL 
INVENTIONS 
Like every other field of technological innovations, patents in 
biotechnology research and innovations can be used for the 
protection of the rights of the researcher to exclude all others 
from the benefits that can be derived from the invention. These 
benefits need not be economic alone as moral rights are also 
protected under intellectual property. This will also enable the 
inventor/researcher have a complete protection and control the 
way the invention works, the way it was made and how it will 
be used. (Mildred 2003) 
 The   justification   for   the   protection   of   biotechnology 
inventions in Intellectual Property laws can be traced to the 
fact  that:  Patents  Laws  give  the  inventor  and  owner  of  
the patent the opportunity to recoup the costs of developing the 
new invention; (Mildred 2003). It also requires that the new 
technology be used for the benefit and advantage of the society 
at  large  because  allowing  the  new  innovation  to  enter  the 
public domain has the potentials to inspire further innovation 
and serve as a rich source of technical information. 
The patent system is one of the ways to facilitate the cross 
boarder   transfer   of   new   technology   from   industrialized 
countries to developing countries though this is not the only 
way to do this and not all types of technology is patented. For 
patent to be carried out successfully there is a need to transfer 
the unpatented source information on how to manufacture and 
produce the patented technology (Date-Bah 2012). There is a 
need  for  the  enactment  of  a  uniform  legislation  that  be 
applicable   to   all   the   member   stated.   This   led   to   the 
promulgation of Trade-Related Aspect of Intellectual Property 
Rights    (TRIPS)    Agreement    1994.    This    International 
Agreement makes provision for a more unified system and 
sets minimum acceptable standards for member states. 
TRIPS also assisted in harmonizing and globalizing legal 
aspects of intellectual property law.  Moreso, it has same 
important provisions on how to acquire and transfer 
technology. Some of these provisions are in Articles 7 and 
27.  For example, Article 7 of the TRIPS makes provision for 
the important role of technology in enhancing socio-
economic welfare of people as follows: 
The  protection  and  enforcement  of  intellectual  property 
rights  should  contribute  to  the  promotion  of  technological 
innovation   and   to   the   transfer   and   dissemination   of 
technology, to the mutual advantage of producer and users of 
technological knowledge and in a manner conducive to social 
and   economic   welfare,   and   to   a   balance   of   rights   
and obligations. Article 27(1), provides further that: Patents 
shall be    available    and    patents    rights    enjoyable    
without discrimination  as  to  the  place  of  invention,  the  
field  of technology  and  whether  products  are  imported  or  
locally produced. 
 The above provisions have turned the issue of patent into 
a  globalised  and  interconnected  one  as  it  not  only  
provides protection  of  member  states  but  also  entails  all  
areas  of technology in the grant of patent. It is important to 
note that the main focus of Article 7 of TRIPS is premised 
upon the idea that users and inventors both have some form 
of leverage. The evolution  of  trips  will  be  of  immense  
benefits  to  many developing  countries  including  Nigeria.  
This  is  because  of provisions such as Article 27 (1) of 
TRIPS Agreement which makes  it  possible  for  holders  of  
a  valid  patent  to  enjoy  the monopoly of being the sole 
importers of their products to the developing countries. This 
is allowed because foreign patent holders often prefer to 
produce their inventions elsewhere and then import them into 
developing countries for sale. The main issue   being   
addressed   with   this   submission   is   that   the developing 
nations, including Nigeria should not give or have an  equal  
treatment  when  it  comes  to  matters  related  to intellectual  
property  like  the  nationals  of  the  developed countries   
(Kur.   2008).   This   is   because   the   developing countries  
do  not  have  the  necessary  technology  required  to create 
inventions such as a good technology base, skills and 
technical  know-how,  well  equipped  research  laboratories 
invention driven policies among others. Developing nations 
therefore, need a form of special treatment as incentive to 
encourage them to develop and then participate meaningfully 
in the international scene of patents and intellectual property. 
If we are to attain real modern trends in biotechnology in the 
coming years, there is a need to explore intellectual property 
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rights. This is because recognition of Intellectual property 
and aspects of trade, management and transferred has the 
potential to influence the trends in biotechnology.  (Becca, A.  
2004). This will no doubt extend the benefits derivable form 
research and  allow  participants  and  researchers  alike  reap  
the  fruits from the sweat of their brows. Several researchers 
have noted that there needs to be a balance between 
biotechnology and distributive justice and as such, 
Intellectual property rights in Biotechnology will further 
enhance this and satisfy the various parties involved in 
research (Becca, A. 2004) There are many aspects of 
intellectual property that may become relevant to the 
discussion on Biotechnology but emphasis will be laid on the 
one that appears most important; Patents. 
 Simply put, a patent may be defined as a right exclusively 
conferred on an inventor which permits him/her to make, sell 
or offer for sale a particular innovation to the exclusion of all 
other  in  the  country  where  the  patent  has  been  granted.  
In Biotechnology, these patents may cover stem cell 
technology, DNA research, interests in body parts, etc. 
(Cohen, J.  2002) 
 
RECOMMENDATIONS 
The existing legal framework should be reformed and should 
include provisions that will allow family members to give or 
withhold consent in cases where the desires of the deceased 
were not known.  Furthermore, the law should be amended 
wherein criminal liabilities are to be separated from the civil 
ones, while imprisonment should be include as punishment 
and not just payment of compensations to victims of illegal 
activities. This may lead to a steady increase in the readily 
available supply organs available for transplantation. Taking   
a   cue   from   the   legal   provisions   in   the   British 
Commonwealth,   Nigeria   could   adopt   this   policy   in   the 
National Health Act as statistics already show that close family 
members are very much willing to donate the organs of 
diseased relatives to help the steady increase in the supply of 
organs and body parts. 
The Nigerian National Health Act should make provisions for 
an encompassing framework for cadaveric donation of organs 
in Nigeria. This, it is hoped, will boost the supply of organs 
needed to meet the transplantation requirement in Nigeria and 
Africa as a whole. There should be a separate legal provision 
aside from the National Health Act that will make specific 
provisions   for   issues   arising   from   organ   donation   and 
transplantation.    This    is    what    is    obtainable    in    other 
jurisdictions around the world and experts have argued that 
this   will   ensure   a   comprehensive   and   all-encompassing 
provision  and  regulatory  mechanisms  such  as  setting  up 
different  committees    and  giving  the  specific  functions  in 
relation to donation and transplantation. There should also an 
online database and networking platforms as well as an organ 
donor register that will enable donors interact with recipients. 
This will enable a seamless connection between potential 
donors and potential recipients. This is what is obtainable in 
advanced countries such as the United States where the UNOS 
is operating. The law should also enable donors under 18 to 
give consent to organ donation where it can be seen that they 
understand the nature of the procedure involved in organ 
donation. 
The proposed Act should also have provision for giving 
oral consent especially in cases of extreme emergencies. The 
process of organ donation must be heavily regulated and the 
Act should have a comprehensive framework on the rules and 
ethics of transplantation. The transplantation should be done 
only     at     accredited     facilities     and     performing     such 
transplantations outside such facilities should constitute a 
grievous offense under the Act for which there will be huge 
sanctions. This will deter people from going into black market 
transplantation with quack doctors. 
There  should  be  provision  of  a  state-of-the-art  intensive 
care  unit  so  that  the  organs  gotten  from  the  donors  can  
beprocessed without wasting time and losing the viability of 
the organs. 
In   addition,   stakeholders   should   embark   on   massive 
enlightenment and educational campaign so as to imbibe the 
need  and  importance  of  organ  donation  and  the  benefits  
of having recognized property in body parts. 
In conclusion, the argument for the recognition of 
proprietary interest and other biological parts/materials have 
argued based on the idea and notion of human dignity for the 
owners of such rights. In essence, their argument was 
premised on the fact that the idea of human dignity is 
premised on the idea of autonomy as every individual   should   
possess   the   right   to   choose   what   is considered 
derogatory for him or her. It is ob 
By contrast, antagonists of this idea are of the opinion that 
dignity has to do with the sanctity of human person and thus, 
recognition of these classes of rights will have the potential 
to diminish the importance and value attached to human 
beings. Commercializing  body  parts  and  organs  will  thus  
lead  to  a whole  spectrum  of  other  evil  deeds  that  will  
devalue  the sanctity  of  life.  A  careful  analysis  of  these  
arguments  was done and then, the study concluded that the 
essentials of an absolute  right  to  make  decisions  will  entail  
the  recognition proprietary interests in organs. If we must 
achieve the desired effects   of   biotechnology   and   organ   
transplantation,   the stakeholders must review the legal 
framework and key into some    of    the    suggestions    made    
above    by    way    of recommendation   and   the,   maybe   
the   future   of   modern medicine  will  have  impacts  on  
the  health  of  Nigerians. 
 Ultimately, biotechnology can only excel for the benefits 
of   mankind   and   the   environment   when   pharmaceutical 
companies, researchers, scholars and government abide by the 
ethical and legal provisions on biotechnology in order to avoid 
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